| Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It offers endocrinology products for diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and paediatric growth conditions. The company also provides neuroscience products for treating depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; migraine and episodic cluster headache; attention-deficit hyperactivity disorder; and schizophrenia. In addition, it offers immunology products for the treatment of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and products to treat erectile dysfunction and benign prostatic hyperplasia. Eli Lilly and Company primarily has collaborations with Incyte Corporation; Pfizer Inc.; Dicerna Pharmaceuticals, Inc.; AC Immune SA; Centrexion Therapeutics Corporation; ImmuNext, Inc.; Avidity Biosciences, Inc.; Duke Clinical Research Institute for the prevention of chronic heart failure and mortality after an acute myocardial infarction; AbCellera Biologics Inc.; Sermonix Pharmaceuticals Inc.; Junshi Biosciences; and Iterative Scopes. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Barnes Melissa S | Chief Eth/Cmpl Ofcr & SVP, ERM | Feb 01 | Option Exercise | 0.00 | 5,445 | 0 | 27,425 | Feb 03 06:29 PM | | Shah Aarti S. | SVP & CIDO | Feb 01 | Option Exercise | 0.00 | 6,282 | 0 | 23,369 | Feb 03 07:02 PM | | Ricks David A | President & CEO | Feb 01 | Option Exercise | 0.00 | 75,387 | 0 | 343,639 | Feb 03 06:57 PM | | Smiley Joshua L | SVP and CFO | Feb 01 | Option Exercise | 0.00 | 19,266 | 0 | 60,702 | Feb 03 08:22 PM | | Zulueta Alfonso G | SVP & President, Lilly Int'l | Feb 01 | Option Exercise | 0.00 | 16,754 | 0 | 35,400 | Feb 03 07:26 PM | | Pusey Leigh Ann | SVP, Corp. Affairs & Comm. | Feb 01 | Option Exercise | 0.00 | 6,282 | 0 | 10,592 | Feb 03 06:51 PM | | O'Neill Myles | SVP & Pres., Mfg. Operations | Feb 01 | Option Exercise | 0.00 | 12,146 | 0 | 56,919 | Feb 03 06:43 PM | | Norton Johna | Senior VP, Global Quality | Feb 01 | Option Exercise | 0.00 | 3,435 | 0 | 20,953 | Feb 03 06:38 PM | | Fry Stephen F | SVP, HR & Diversity | Feb 01 | Option Exercise | 0.00 | 15,078 | 0 | 115,289 | Feb 03 06:33 PM | | LILLY ENDOWMENT INC | 10% Owner | Jan 15 | Sale | 190.80 | 215,000 | 41,022,862 | 110,487,343 | Jan 19 01:04 PM | | LILLY ENDOWMENT INC | 10% Owner | Jan 13 | Sale | 185.97 | 210,000 | 39,053,064 | 110,702,343 | Jan 14 11:23 AM | | LILLY ENDOWMENT INC | 10% Owner | Jan 11 | Sale | 185.49 | 220,000 | 40,807,754 | 110,912,343 | Jan 12 11:27 AM | | Smiley Joshua L | SVP and CFO | Oct 01 | Option Exercise | 0.00 | 7,947 | 0 | 44,918 | Oct 05 12:19 PM | | Barnes Melissa S | Chief Eth/Cmpl Ofcr & SVP, ERM | Sep 08 | Sale | 151.01 | 5,000 | 755,050 | 23,580 | Sep 10 04:25 PM | | Mason Michael B | Sr. VP & Pres., Lilly Diabetes | Sep 01 | Option Exercise | 0.00 | 6,244 | 0 | 21,279 | Sep 02 05:04 PM | | Fry Stephen F | SVP, HR & Diversity | Aug 17 | Sale | 150.64 | 7,204 | 1,085,211 | 100,211 | Aug 18 03:31 PM | | LILLY ENDOWMENT INC | 10% Owner | Jul 09 | Sale | 169.69 | 12,961 | 2,199,392 | 111,132,343 | Jul 10 02:16 PM | | Zulueta Alfonso G | SVP & President, Lilly Int'l | Jul 09 | Sale | 170.00 | 11,000 | 1,870,000 | 18,646 | Jul 13 01:43 PM | | LILLY ENDOWMENT INC | 10% Owner | Jul 07 | Sale | 167.29 | 210,000 | 35,131,799 | 111,145,304 | Jul 08 12:49 PM | | LILLY ENDOWMENT INC | 10% Owner | Jul 06 | Sale | 166.99 | 205,000 | 34,232,086 | 111,379,612 | Jul 07 02:27 PM | | Pusey Leigh Ann | SVP, Corp. Affairs & Comm. | Jul 05 | Option Exercise | 0.00 | 2,468 | 0 | 5,424 | Jul 06 04:50 PM | | LILLY ENDOWMENT INC | 10% Owner | Jun 30 | Sale | 163.20 | 166,832 | 27,227,760 | 111,560,304 | Jul 01 11:17 AM | | LILLY ENDOWMENT INC | 10% Owner | Jun 29 | Sale | 163.39 | 11,431 | 1,867,760 | 111,727,136 | Jun 30 03:12 PM | | LILLY ENDOWMENT INC | 10% Owner | Jun 26 | Sale | 163.01 | 31,737 | 5,173,404 | 111,738,567 | Jul 01 09:55 AM | | LILLY ENDOWMENT INC | 10% Owner | Jun 26 | Sale | 163.01 | 31,737 | 5,173,404 | 111,738,567 | Jun 30 02:48 PM | | LILLY ENDOWMENT INC | 10% Owner | Jun 18 | Sale | 161.54 | 53,770 | 8,686,046 | 111,770,304 | Jun 19 02:21 PM | | LILLY ENDOWMENT INC | 10% Owner | Jun 17 | Sale | 161.38 | 161,230 | 26,019,469 | 111,824,074 | Jun 18 05:16 PM | | Zulueta Alfonso G | SVP & President, Lilly Int'l | Jun 16 | Sale | 162.94 | 17,000 | 2,770,000 | 29,646 | Jun 18 09:36 AM | | LILLY ENDOWMENT INC | 10% Owner | Jun 16 | Sale | 162.92 | 212,337 | 34,593,145 | 111,985,304 | Jun 17 03:13 PM | | Zulueta Alfonso G | SVP & President, Lilly Int'l | Jun 05 | Sale | 150.00 | 10,000 | 1,500,000 | 46,646 | Jun 09 04:52 PM | | LILLY ENDOWMENT INC | 10% Owner | Apr 27 | Sale | 163.60 | 12,663 | 2,071,715 | 112,197,641 | Apr 28 12:21 PM | | LILLY ENDOWMENT INC | 10% Owner | Apr 24 | Sale | 162.47 | 220,000 | 35,743,218 | 112,210,304 | Apr 27 02:36 PM | | LILLY ENDOWMENT INC | 10% Owner | Apr 23 | Sale | 160.12 | 230,000 | 36,826,587 | 112,430,304 | Apr 27 10:39 AM | | Shah Aarti S. | SVP & CIO | Apr 14 | Sale | 150.00 | 2,000 | 300,000 | 19,087 | Apr 16 11:23 AM | | LILLY ENDOWMENT INC | 10% Owner | Apr 09 | Sale | 145.42 | 230,000 | 33,445,542 | 112,660,304 | Apr 13 02:43 PM | | LILLY ENDOWMENT INC | 10% Owner | Apr 07 | Sale | 143.20 | 172,315 | 24,676,281 | 112,890,304 | Apr 08 12:49 PM | | LILLY ENDOWMENT INC | 10% Owner | Apr 06 | Sale | 142.73 | 15,962 | 2,278,322 | 113,062,619 | Apr 07 11:40 AM | | LILLY ENDOWMENT INC | 10% Owner | Apr 03 | Sale | 143.19 | 26,723 | 3,826,493 | 113,078,581 | Apr 06 02:42 PM | | LILLY ENDOWMENT INC | 10% Owner | Apr 02 | Sale | 140.78 | 166,038 | 23,374,654 | 113,105,304 | Apr 03 12:42 PM | | LILLY ENDOWMENT INC | 10% Owner | Mar 31 | Sale | 140.07 | 38,962 | 5,457,474 | 113,271,342 | Apr 01 01:47 PM | | LILLY ENDOWMENT INC | 10% Owner | Mar 30 | Sale | 139.11 | 210,000 | 29,213,559 | 113,310,304 | Mar 31 04:03 PM | | Fry Stephen F | SVP, HR & Diversity | Mar 30 | Sale | 134.30 | 14,657 | 1,968,434 | 107,415 | Mar 31 11:50 AM | | Norton Johna | Senior VP, Global Quality | Mar 16 | Sale | 131.00 | 4,727 | 619,237 | 17,674 | Mar 18 10:44 AM | | O'Neill Myles | SVP & Pres., Mfg. Operations | Mar 04 | Sale | 140.15 | 25,000 | 3,503,750 | 8,469 | Mar 06 10:46 AM | | Zakrowski Donald A | Chief Accounting Officer | Mar 02 | Sale | 128.00 | 3,700 | 473,600 | 4,740 | Mar 03 03:27 PM |
|
